Kimmel, G., Chima, M., Kim, H. J., Bares, J., Yaroshinsky, A., Singer, G., Kim, S. J., Bagel, J., & Lebwohl, M. (2021). Brodalumab in the treatment of moderate-to-severe psoriasis in patients refractory to anti-interleukin-17A therapies: Evaluation of secondary endpoints. SKIN The Journal of Cutaneous Medicine, 5(5), 524–529. https://doi.org/10.25251/skin.5.5.10